BRIEF-Regeneron and Sanofi announce Kevzara license application resubmission for review by FDA
* Regeneron and Sanofi announce Kevzara® (sarilumab) Biologics License Application resubmission accepted for review by U.S. FDA
NEW YORK, Sept 30 Wall Street rallied on Friday, lifted by a surge in Deutsche Bank shares and financial stocks after concerns eased about the health of the German bank.
The Dow Jones industrial average rose 164.63 points, or 0.91 percent, to 18,308.08, the S&P 500 gained 17.09 points, or 0.79 percent, to 2,168.22 and the Nasdaq Composite added 42.85 points, or 0.81 percent, to 5,312.00. (Reporting by Chuck Mikolajczak; Editing by Nick Zieminski)
* Korea stocks, won down after Trump says trade deal needs change
BEIJING, April 28 Toshiba Corp's Westinghouse Electric Co unit will continue operating normally despite the ongoing Chapter 11 restructuring, an executive at the troubled company said on Friday.